ClinicalTrials.govpublic full text
Nivolumab and Oral Cyclophosphamide for R/R AML and HIgh Risk MDS
acute myeloid leukemia, higher risk myelodysplastic syndrome, aml, mds, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 861681
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.